期刊文献+

Serum uric acid levels correlate with atrial fibrillation in patients with chronic systolic heart failure 被引量:20

Serum uric acid levels correlate with atrial fibrillation in patients with chronic systolic heart failure
原文传递
导出
摘要 Background Studies have shown that increased levels of serum uric acid (SUA) are associated with atrial fibrillation (AF). However, less is known about the prognostic value of SUA levels for AF in patients with chronic heart failure (CHF). The aim of the study was to examine the prognostic value of SUA levels for AF in patients with CHF. Methods Sixteen thousand six hundred and eighty-one patients diagnosed with CHF from 12 hospitals were analyzed. Patients were categorized into AF group and non-AF group, death group, and survival group according to the results of the patients' medical records and follow-up. Univariate and multivariate Cox proportional hazards analyses were performed to examine the risk of AF. The sensitivity and specificity of SUA level in predicting the prognosis were examined by multivariate Cox models and receiver operating characteristic (ROC) curves. Results The results of univariate predictors in overall patients showed that the higher SUA level was associated with AF. SUA level (HR, 1.084; 95% CI, 1.017-1.144; P 〈0.001), diuretics (HR, 1.549; 95% CI, 1.246-1.854; P 〈0.001), and New York Heart Association (NYHA) (HR, 1.237; 95% CI, 1.168-1.306; P 〈0.001) function class were the independent risk factors for AF. The sensitivity and specificity of the models were 29.6% and 83.8% respectively for predicting AF. When SUA level was added to these models, it remained significant (Wald Z2, 1494.88; P 〈0.001 for AF); 58.8% (95% CI, 57.7%-60.0%) of the observed results were concordant with the separate model. Conclusion Higher SUA level is associated strongly with AF in patients with CHF. SUA level can increase the sensitivity and specificity in predicting AF. Background Studies have shown that increased levels of serum uric acid (SUA) are associated with atrial fibrillation (AF). However, less is known about the prognostic value of SUA levels for AF in patients with chronic heart failure (CHF). The aim of the study was to examine the prognostic value of SUA levels for AF in patients with CHF. Methods Sixteen thousand six hundred and eighty-one patients diagnosed with CHF from 12 hospitals were analyzed. Patients were categorized into AF group and non-AF group, death group, and survival group according to the results of the patients' medical records and follow-up. Univariate and multivariate Cox proportional hazards analyses were performed to examine the risk of AF. The sensitivity and specificity of SUA level in predicting the prognosis were examined by multivariate Cox models and receiver operating characteristic (ROC) curves. Results The results of univariate predictors in overall patients showed that the higher SUA level was associated with AF. SUA level (HR, 1.084; 95% CI, 1.017-1.144; P 〈0.001), diuretics (HR, 1.549; 95% CI, 1.246-1.854; P 〈0.001), and New York Heart Association (NYHA) (HR, 1.237; 95% CI, 1.168-1.306; P 〈0.001) function class were the independent risk factors for AF. The sensitivity and specificity of the models were 29.6% and 83.8% respectively for predicting AF. When SUA level was added to these models, it remained significant (Wald Z2, 1494.88; P 〈0.001 for AF); 58.8% (95% CI, 57.7%-60.0%) of the observed results were concordant with the separate model. Conclusion Higher SUA level is associated strongly with AF in patients with CHF. SUA level can increase the sensitivity and specificity in predicting AF.
出处 《Chinese Medical Journal》 SCIE CAS CSCD 2012年第10期1708-1712,共5页 中华医学杂志(英文版)
关键词 atrial fibrillation uric acid chronic heart failure DIURETICS atrial fibrillation uric acid chronic heart failure diuretics
  • 相关文献

参考文献20

  • 1Wang T J, Larson MG, Levy D, Vasan RS, Leip EP, Wolf PA, et al. Temporal relations of atrial fibrillation and congestive heart failure and their joint influence on mortality: the Framingham Heart Study. Circulation 2003; 107: 2920-2925.
  • 2Kannel WB, Abbott RD, Savage DD, McNamara PM. Epidemiologic features of chronic atrial fibrillation: the Framingham study. N Engl J Med 1982; 306: 1018-1022.
  • 3Burstein B, Nattel S. Atrial fibrosis: mechanisms and clinical relevance in atrial fibrillation. J Am Coll Cardiol 2008; 51: 802-809.
  • 4Torre-Amione G, Kapadia S, Lee J, Durand JB, Bies RD, Young JB, et al. Tumor necrosis factor-alpha and tumor necrosis factor receptors in the failing human heart. Circulation 1996; 93: 704-711.
  • 5Mary K, Amir G Michael JS. Increased oxidative stress in patients with congestive heart failure. J Am Coil Cardiol 1998; 31: 1352-1356.
  • 6Engelmann MD, Svendsen JH. Inflammation in the genesis and perpetuation of atrial fibrillation. Eur Heart J 2005; 26: 2083-2092.
  • 7Strazzullo P, Puig JG. Uric acid and oxidative stress: relative impact on cardiovascular risk? Nutr Metab Cardiovasc Dis 2007; 17: 409-414.
  • 8Jankowska EA, Panikowska B, Majda J, Zymlinski R, Trzaska M, Reczuch K, et al. Hyperuricemia predicts poor outcome in patients with mild to moderate HF. Int J Cardiol 2007; 115: 151-155.
  • 9Dickstein K, Cohen-Solal A, Filippatos G, McMurray JJ, Ponikowski P, Poole-Wilson PA, et al. ESC Committee for Practice Guidelines ESC. Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Eur Heart J 2008; 29: 2388-2442.
  • 10Maisel WH, Stevenson LW. Atrial fibrillation in heart failure: epidemiology, pathophysiology, and rationale for therapy. Am J Cardiol 2003; 91: D2-D8.

同被引文献72

引证文献20

二级引证文献117

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部